Andorra vs Mauritania: The number of people with susceptibility test result for rifampicin
Andorra
2
in 2021
Mauritania
0
in 2021
Andorra rank
143rd
Mauritania rank
146th
The number of people with susceptibility test result for rifampicin over time
- Andorra
- Mauritania
How they compare
Andorra currently reports 2 against 0 in Mauritania, a difference of 2.
The two have swapped places 1 time across 5 shared years of data; in 2017 it was Mauritania ahead.
Andorra ranks 143rd and Mauritania ranks 146th of 155 countries.
Across the 2 decades both report, Andorra averaged higher in 1 and Mauritania in 1.
Head to head by decade
| Decade | Andorra | Mauritania | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 1.33 | 3 | 1.67 | Mauritania |
| 2020s | 1.5 | 0 | 1.5 | Andorra |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Andorra or Mauritania?
- Andorra, at 2 against 0 in Mauritania as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Andorra and Mauritania?
- 2, with Andorra ahead.
- How many years of comparable data are there for Andorra and Mauritania?
- 5 years are reported by both, from 2017 to 2021.
- How do Andorra and Mauritania rank globally for the number of people with susceptibility test result for rifampicin?
- Andorra ranks 143rd and Mauritania ranks 146th of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.